Tech Company Financing Transactions
JenaValve Technology Funding Round
JenaValve Technology, based in Irvine, secured $50 million in investment from Bain Capital Life Sciences, Andera Partners and GIMV.
Transaction Overview
Company Name
Announced On
2/6/2020
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This financing supports our ongoing clinical program and plans to file for U.S. Humanitarian Device Exemption (HDE) approval in the second half of 2020.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7545 Irvine Center Dr. 100
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
In 2006 the company was founded to develop second generation transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Kilcoyne
Chief Financial Officer
Peter Wulff
VP - Operations
Jeff Thiel
VP - R & D
Greg Mirigian
VP - Regulatory Affairs
Janet Fauls
VP - Regulatory Affairs
Vinny Podichetty
Browse more venture capital transactions:
Prev: 2/6/2020: Houwzer venture capital transaction
Next: 2/6/2020: Rad Power Bikes venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs